Amarin to Present at the Jefferies 2016 London Healthcare Conference


BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 11, 2016 -- Amarin Corporation plc , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's president and chief executive officer, is scheduled to present a general company update at the Jefferies 2016 London Healthcare Conference on Thursday, November 17, 2016, at 9:00 am EST or 2:00 pm GMT. Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.



from Biotech News